Kimberly Maxfield

890 total citations
15 papers, 523 citations indexed

About

Kimberly Maxfield is a scholar working on Pediatrics, Perinatology and Child Health, Immunology and Molecular Biology. According to data from OpenAlex, Kimberly Maxfield has authored 15 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Kimberly Maxfield's work include Pharmaceutical studies and practices (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Pharmaceutical Economics and Policy (4 papers). Kimberly Maxfield is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Pharmaceutical Economics and Policy (4 papers). Kimberly Maxfield collaborates with scholars based in United States, Netherlands and France. Kimberly Maxfield's co-authors include Ann Pascale Bijnens, Victor W.M. van Hinsbergh, Hans Duimel, Judith C. Sluimer, Peter M. Frederik, Erica Pacheco, Frank D. Kolodgie, Renu Virmani, Mat J.A.P. Daemen and Angelique W. Whitehurst and has published in prestigious journals such as JAMA, Nature Communications and Journal of the American College of Cardiology.

In The Last Decade

Kimberly Maxfield

15 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberly Maxfield United States	8	221	137	127	122	95	15	523
Francine E. Carrick United States	9	308 1.4×	78 0.6×	105 0.8×	101 0.8×	63 0.7×	10	604
Alexandre C. Zago Brazil	8	188 0.9×	211 1.5×	77 0.6×	123 1.0×	155 1.6×	12	591
Dusten Unruh United States	13	215 1.0×	187 1.4×	92 0.7×	71 0.6×	105 1.1×	20	661
Murat Serilmez Türkiye	15	198 0.9×	114 0.8×	93 0.7×	59 0.5×	35 0.4×	34	570
Gamal Andre Banat Germany	5	260 1.2×	84 0.6×	322 2.5×	78 0.6×	84 0.9×	6	592
Sherry Bullens United States	10	275 1.2×	65 0.5×	62 0.5×	48 0.4×	81 0.9×	13	578
Francesca Simionato Italy	17	290 1.3×	111 0.8×	199 1.6×	125 1.0×	86 0.9×	31	794
Hirotaka Okamoto Japan	15	331 1.5×	120 0.9×	161 1.3×	226 1.9×	34 0.4×	46	810
Gengqian Cai United States	8	136 0.6×	95 0.7×	71 0.6×	51 0.4×	85 0.9×	13	359

Countries citing papers authored by Kimberly Maxfield

Since Specialization

Citations

This map shows the geographic impact of Kimberly Maxfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Maxfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Maxfield more than expected).

Fields of papers citing papers by Kimberly Maxfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Maxfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Maxfield. The network helps show where Kimberly Maxfield may publish in the future.

Co-authorship network of co-authors of Kimberly Maxfield

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Maxfield. A scholar is included among the top collaborators of Kimberly Maxfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Maxfield. Kimberly Maxfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hon, Yuen Yi, Anand Balakrishnan, Lin Zhou, et al.. (2023). Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins. The AAPS Journal. 25(4). 54–54. 6 indexed citations

Maxfield, Kimberly & Issam Zineh. (2021). Precision Dosing. JAMA. 325(15). 1505–1505. 16 indexed citations

Guinn, Daphne, et al.. (2020). Communicating Immunogenicity-Associated Risk in Current U.S. FDA Prescription Drug Labeling: A Systematic Evaluation. Therapeutic Innovation & Regulatory Science. 54(6). 1363–1371. 1 indexed citations

Maxfield, Kimberly, Daniel González, Qi Liu, et al.. (2020). Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real‐World Setting. Clinical Pharmacology & Therapeutics. 109(1). 25–28. 16 indexed citations

Madabushi, Rajanikanth, Jeffry Florian, Anuradha Ramamoorthy, et al.. (2020). Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and Use. Clinical Pharmacology & Therapeutics. 108(4). 710–715. 1 indexed citations

Maxfield, Kimberly, et al.. (2020). A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response‐Guided Titration. Clinical Pharmacology & Therapeutics. 109(1). 123–130. 1 indexed citations

Guinn, Daphne, Rajanikanth Madabushi, Yow‐Ming Wang, Issam Zineh, & Kimberly Maxfield. (2020). Elucidating the Impact of Immunogenicity Assessment Postapproval: A Targeted Analysis of Immunogenicity Postmarketing Requirements and Commitments. Clinical Pharmacology & Therapeutics. 109(3). 697–704. 7 indexed citations

Thway, Theingi M., et al.. (2019). Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development. The AAPS Journal. 22(1). 15–15. 3 indexed citations

Bruno, René, Jin Y. Jin, Kimberly Maxfield, et al.. (2019). Proceedings of a Workshop: US Food and Drug Administration‐International Society of Pharmacometrics Model‐Informed Drug Development in Oncology. Clinical Pharmacology & Therapeutics. 106(1). 81–83. 1 indexed citations

10.

Maxfield, Kimberly, et al.. (2017). The Role of Public–Private Partnerships in Catalyzing the Critical Path. Clinical and Translational Science. 10(6). 431–442. 16 indexed citations

11.

Maxfield, Kimberly, et al.. (2016). SIK2 Restricts Autophagic Flux To Support Triple-Negative Breast Cancer Survival. Molecular and Cellular Biology. 36(24). 3048–3057. 22 indexed citations

12.

Maxfield, Kimberly, Kathleen Corcoran, Joshua S. Wooten, et al.. (2015). Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer. Nature Communications. 6(1). 8840–8840. 89 indexed citations

13.

Markowetz, Florian, Carles Pons, Christina Laufer, et al.. (2015). Systems Genetics. Cambridge University Press eBooks. 4 indexed citations

14.

Cappell, Kathryn M., et al.. (2012). Multiple Cancer Testis Antigens Function To Support Tumor Cell Mitotic Fidelity. Molecular and Cellular Biology. 32(20). 4131–4140. 65 indexed citations

15.

Sluimer, Judith C., Frank D. Kolodgie, Ann Pascale Bijnens, et al.. (2009). Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial Junctions. Journal of the American College of Cardiology. 53(17). 1517–1527. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact